Prosight Management, LP Neogenomics Inc Transaction History

Prosight Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $448,479 - $887,430	-63,524 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $771,816 - $2.24 Million	63,524 New	63,524 $772,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $1.29 Million - $1.57 Million	-38,819 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $939,807 - $1.2 Million	38,819 New	38,819 $1.2 Million

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.